Biocytogen
688796106.371.51% ( -1.63 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Biocytogen(688796) the Revenue is 433.06 M (+73.68%);the EBIT is 133.93 M (+1120%);the EPS is 0.23 (+866.7%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.43B73.68%
----
----
EBIT
0.13B1120.15%
----
----
EPS
0.23866.67%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf